Iron Bridge Private Wealth, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Iron Bridge Private Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $44,634 - $52,382	-75 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$543.48 - $670.97 $16,304 - $20,129	30 Added 66.67%	75 $47,000
Q3 2021 Jan 12, 2022	BUY	$574.03 - $680.96 $25,831 - $30,643	45 New	45 $27,000
Q2 2021 Sep 01, 2021	SELL	$472.8 - $558.54 $20,330 - $24,017	-43 Closed	0 $0
Q4 2020 Mar 24, 2021	BUY	$478.3 - $607.98 $20,566 - $26,143	43 New	43 $21,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Iron Bridge Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Iron Bridge Private Wealth, LLC with notifications on news.